H-Ala-Leu-OH

CAS: 3303-34-2

Ref. 3D-FA107967

Información del producto

• Nombre: H-Ala-Leu-OH
• Sinónimos: 1: PN: JP2007217358 SEQID: 1 claimed protein, 72: PN: WO2014170713 SEQID: 178 claimed protein, 933: PN: EP2071334 SEQID: 994 claimed protein, 933: PN: WO2009077864 SEQID: 994 claimed protein, <span class="text-smallcaps">L</smallcap>-Alanyl-<smallcap>L</span>-leucine, <span class="text-smallcaps">L</smallcap>-Leucine, <smallcap>L</span>-alanyl-, <span class="text-smallcaps">L</smallcap>-Leucine, N-<smallcap>L</span>-alanyl-, Alanylleucine, L-Alanyl-L-leucine, Leucine, N-<span class="text-smallcaps">L</smallcap>-alanyl-, <smallcap>L</span>-, NSC 89609, L-Leucine, L-alanyl-, Leucine, N-L-alanyl-, L-, L-Leucine, N-L-alanyl-

Descripción

H-Ala-Leu-OH is a chemical compound that is found in urine samples. It has been shown to have antibacterial activity against the E. coli K-12 strain, and also has the ability to bind to the bacterial cell wall. This molecule can be synthesized by solid-phase synthesis from H-Ala-OH and L-Leu-OH, which are commercially available. This amino acid can form a disulfide bond with cysteine residues of subtilisin, which prevents formation of a disulfide bridge between two cysteine residues in subtilisins. The alcohol-induced liver injury model in rats showed that H-Ala-Leu-OH reduced the hepatic injury as well as the glomerular filtration rate in bovines. It has also been shown to reduce fatty acid levels in rats with intestinal inflammation, indicating it may have therapeutic potential for this condition.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 202.25 g/mol
• Fórmula: C₉H₁₈N₂O₃
• Pureza: Min. 95%